Clinical Trials in Atlanta

Showing 1201-1220 of 16,968 trials

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

NCT02829918

This research study is designed to see if a drug called Nivolumab is effective in treating patients with advanced refractory biliary tract cancers. Nivolumab has been approved by the U.S. Food and Drug Administration (FDA) for treatment of certain types of cancer but is not approved by the FDA for treatment of your type of cancer.

Biliary Tract CancerBiliary Tract Neoplasms

H. Lee Moffitt Cancer Center and Research Institute54 participantsStarted Oct 2016

Duarte, California, United States • Tampa, Florida, United States • Atlanta, Georgia, United States

Active Not RecruitingNA17 miles

AMPLATZER PFO Occluder Post Approval Study

NCT03309332

The purpose of this single arm, multi-center study is to confirm the safety and effectiveness of the AMPLATZER™ PFO Occluder in the post Approval Setting.

StrokePatent Foramen Ovale

Abbott Medical Devices1,214 participantsStarted Jan 2018

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Chandler, Arizona, United States +85 more locations

Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers

AMPLATZER PFO Occluder Post Approval Study

Find Trials by Condition in Atlanta

Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018

Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

PROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors

Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C Mutation

BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S

Secukinumab Open Label Roll-over Extension Protocol

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer

Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD

Screening for Prostate Cancer Using High Resolution Micro-ultrasound Versus Multiparametric Magnetic Resonance Imaging.